Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis.
about
SGLT2 Inhibitors: Benefit/Risk Balance.Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes.Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association.Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes.
P2860
Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of empagli ...... atic review and meta-analysis.
@ast
Efficacy and safety of empagli ...... atic review and meta-analysis.
@en
type
label
Efficacy and safety of empagli ...... atic review and meta-analysis.
@ast
Efficacy and safety of empagli ...... atic review and meta-analysis.
@en
prefLabel
Efficacy and safety of empagli ...... atic review and meta-analysis.
@ast
Efficacy and safety of empagli ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Efficacy and safety of empagli ...... atic review and meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00228-016-2010-8
P577
2016-02-01T00:00:00Z